Potential cost savings from chemotherapy-induced febrile neutropenia with biosimilar filgrastim and expanded access to targeted antineoplastic treatment across the european union G5 countries: A simulation study

Diana Sun, Tri Murti Andayani, Ahmed Altyar, Karen Macdonald, Ivo Abraham

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Potential cost savings from chemotherapy-induced febrile neutropenia with biosimilar filgrastim and expanded access to targeted antineoplastic treatment across the european union G5 countries: A simulation study'. Together they form a unique fingerprint.

Medicine & Life Sciences